Clinical Implications of the Phase III BMT CTN 1703 Trial
Experts review the Phase III BMT CTN 1703 trial and share how the results of this trial might impact their practice and discuss the role of ATG and abatacept in their practice
EP: 1.An Overview of Graft vs Host Disease (GvHD)
EP: 2.Regimens Used for GvHD Prevention
Now Viewing
EP: 3.Clinical Implications of the Phase III BMT CTN 1703 Trial
EP: 4.Future of Acute GvHD Prevention
EP: 5.Acute GvHD: Clinical Presentation, Risk Factors and Treatment Options
EP: 6.Steroid Refractory Acute GvHD and REACH Trials
Related Videos
View All
Related Content
Magrolimab Plus Rituximab/Chemo Elicits Deep Responses in Relapsed/Refractory DLBCL
January 28th 2023
Magrolimab Plus Rituximab/Chemo Elicits Deep Responses in Relapsed/Refractory DLBCL
January 28th 2023
